Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

116.57
+5.685.12%
Post-market: 117.000.4300+0.37%19:59 EDT
Volume:2.96M
Turnover:345.25M
Market Cap:29.28B
PE:-15.00
High:120.33
Open:110.92
Low:110.89
Close:110.89
52wk High:124.00
52wk Low:79.52
Shares:251.20M
Float Shares:108.00M
Volume Ratio:1.03
T/O Rate:2.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7726
EPS(LYR):-5.5184
ROE:-9.30%
ROA:-5.41%
PB:1.41
PE(LYR):-21.12

Loading ...

Biontech SE Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

BioNTech Lowers 2026 Sales Outlook as COVID Vaccine Demand Softens

Reuters
·
Aug 04

Why Pfizer Stock and This Covid Vaccine Partner are Falling on Earnings

Dow Jones
·
Aug 04

Biontech Appoints Guido Oelkers as CEO Effective by February 1, 2027

Reuters
·
Aug 04

BioNTech Q2 Revenue EUR 105.6 Million

Reuters
·
Aug 04

GUIDANCE: (BNTX) BioNTech Expects 2026 Revenue Range 1.60B Euros - 1.90B Euros, vs. FactSet Est of 2.16B Euros

MT Newswires Live
·
Aug 04

Earnings Flash (BNTX) BioNTech Posts Q2 Adjusted Loss 2.22 Euros a Share, vs. FactSet Est of 1.99 Euros Loss

MT Newswires Live
·
Aug 04

Stock Track | BioNTech Plunges 5.15% in Pre-market After Q2 Earnings Miss Estimates

Stock Track
·
Aug 04

BioNTech Q2 2026 Net Loss Widens to €820.8 Million; Revenue Drops 59.52% to €105.6 Million vs Q2 2025

Reuters
·
Aug 04

BioNTech Q2 Adj. EPS $(2.58) Misses $(2.34) Estimate, Sales $122.766M Miss $182.020M Estimate

Benzinga Earnings
·
Aug 04

Press Release: BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update

Dow Jones
·
Aug 04

Stocks to Watch: Palantir, SpaceX, HSBC

Dow Jones
·
Aug 04

BioNTech Names Ex-Sobi Chief Guido Oelkers as CEO, Succeeding Ugur Sahin

Reuters
·
Aug 03

Biontech SE Expected to Post a Loss of €2.09 a Share - Earnings Preview

Reuters
·
Jul 31

Sansure Biotech Gets Device Registration Certificate for COVID-19, Flu, RSV Detection Kits

MT Newswires Live
·
Jul 30

BioNTech (BNTX) Could Be 81% Undervalued After New Vaccine Patent Lawsuits

Simply Wall St.
·
Jul 30

BioNTech and Pfizer Secure EU Approval for XFG-Adapted COVID-19 Vaccine for 2026-2027 Season

TIPRANKS
·
Jul 30

Pfizer, BioNTech Updated Covid Vaccine Gets Europe Approval

Dow Jones
·
Jul 30

EU Authorizes Pfizer-BioNTech XFG-adapted COVID Vaccine for Ages 6 Months and Up

Reuters
·
Jul 30

Earning Preview: BioNTech SE Q2 revenue is expected to increase by 6%, institutional views are leaning cautious

Earnings Agent
·
Jul 29